Coherus Oncology, Inc. (CHRS)
1.58
0.00 (0.00%)
USD |
NASDAQ |
Mar 19, 13:38
Coherus Oncology Profit Margin (Quarterly) : -363.6% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Johnson & Johnson | 20.83% |
| Stereotaxis, Inc. | -64.00% |
| Allogene Therapeutics, Inc. | -- |
| Inovio Pharmaceuticals, Inc. | -- |
| Nektar Therapeutics | -165.4% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -44.72% |
| Return on Invested Capital | -128.2% |
| Gross Profit Margin (Quarterly) | 61.24% |
| Operating Margin (Quarterly) | -359.9% |
| Return on Net Operating Assets | -173.2% |